Invacare Corporation
IVC · NYSE
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -8.7% | 6.4% | -9.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 26.5% | 26.6% | 18.4% | 25.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -6% | -15.2% | -14.1% | -5.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -24.9% | -11.3% | -20.2% | -11.6% |
| EPS Diluted | -1.08 | -0.56 | -0.91 | -0.61 |
| % Growth | -92.9% | 38.5% | -49.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |